Valence 로고
인기
로그인
Loading data for ELDN — first visit, this takes a few seconds.

관심목록에 추가

Eledon Pharmaceuticals In...

NasdaqCM: ELDN · 실시간 가격 · USD
3.52
-0.03 (-0.85%)
종가 기준: Aug 20, 2026, 8:00 PM

주가와 핵심 숫자, 최신 뉴스를 한 곳에 모았습니다.

Eledon Pharmaceuticals Inc.(ELDN) 주가, 분석 및 데이터

-0.85%

데이터 없음

매수호가2.61
시가총액286.04M
매출 (ttm)n/a
순이익 (ttm)-98.56M
0.96
-0.9
n/a
-4.57
P/B (ttm)2.66
P/S (ttm)n/a
실적 발표일Nov 13, 2026
매도호가4.51
거래량576,037
평균 거래량 (20일)1,271,183
시가3.53
전일 종가3.55
일중 범위3.42 - 3.59
52주 범위1.35 - 4.60
애널리스트n/a
목표주가n/a
배당n/a
배당락일n/a

ELDN 소개

Eledon Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It uses its immunology expertise in targeting the CD40 Ligand (CD40L) pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat amyotrophic lateral sclerosis (ALS). The company's lead compound in development is tegoprubart, an IgG1 and anti-CD40L antibody with high affinity for CD40 Ligand, a biological target with therapeutic po...

[더 보기]
산업 Biotechnology
섹터 Healthcare
IPO 일자 Sep 17, 2014
직원 수 33
상장 거래소 NasdaqCM
티커 ELDN
웹사이트 https://eledon.com
전체 기업 정보

재무 실적

2025년 Eledon Pharmaceuticals의 매출은 0로, 전년 0 대비 undefined% 증가했습니다. 순이익은 -45.62M로, 26.07% 증가했습니다.

재무제표

어닝 서프라이즈

Eledon Pharmaceuticals가 Aug 13, 2026에 분기 실적을 발표했습니다:
  • 매출 $0 예상치 하회 $0, 및 NaN% 전년 대비 성장.
  • EPS -0.27 예상치 하회 -0.12, 및 -107.69% 전년 대비 감소.

    • 다음 실적 발표

    Eledon Pharmaceuticals Inc.의 실적 발표 예정일은 Nov 13, 2026, 정규장 중입니다.
    애널리스트 예상 매출은 ... 업그레이드
    news image

    2개월 전 · Zacks

    Is Eledon Pharmaceuticals (ELDN) Outperforming Other Medical Stocks This Year?

    Here is how Eledon Pharmaceuticals, Inc. (ELDN) and Galderma Group AG - Unsponsored ADR (GALDY) have performed compared to their sector so far this year.

    news image

    2개월 전 · Insider Monkey

    Eledon Pharmaceuticals (ELDN) Announces Updated Results From Investigator-Initiated Trial Evaluating tegoprubart

    While Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) has gained 125.83% year-to-date, analysts continue to see 134.60% upside, helping it secure a spot on our list of the hot biotech stocks under $5 to bu...

    news image

    2개월 전 · Zacks

    Is BillionToOne, Inc. (BLLN) Stock Outpacing Its Medical Peers This Year?

    Here is how BillionToOne (BLLN) and Eledon Pharmaceuticals, Inc. (ELDN) have performed compared to their sector so far this year.

    news image

    3개월 전 · Benzinga

    EXCLUSIVE: NewcelX Eyes Accelerated 2026 Execution For Diabetes Drug

    NewcelX Ltd. reported its 2025 financial results, with leadership emphasizing a "transformative year" marked by merger completion, balance sheet improvements, and progress in its lead Type 1 diabetes ...

    news image

    4개월 전 · Insider Monkey

    Here is Why Eledon Pharmaceuticals (ELDN) is an Unstoppable Stock That Could Double Your Money

    Eledon Pharmaceuticals Inc. (NASDAQ:ELDN) is one of the 10 Unstoppable Stocks That Could Double Your Money. Eledon Pharmaceuticals Inc. (NASDAQ:ELDN) is one of the unstoppable stocks that could double...

    2 페이지 중 1